Exenatide vs Icotrokinra
Overview
Exenatide is primarily a weight management & metabolic peptide, while Icotrokinra is used for immune support.
This page compares Exenatide and Icotrokinra across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Exenatide | Icotrokinra | |
|---|---|---|
| Category | Weight Management & Metabolic | Immune Support |
| Regulatory status (US) | FDA approved | FDA approved |
| Typical dosage | 5–10 mcg (Byetta) or 2 mg (Bydureon/Bydureon BCise) | — |
| Frequency | Twice daily (Byetta) or once weekly (Bydureon) | — |
| Reported benefits | Glycemic control (HbA1c reduction 0.8–1.9 percentage points), modest body weight reduction (2–4 kg), low intrinsic hypoglycemia risk, modest systolic blood pressure reduction, cardiovascular non-inferiority established in EXSCEL | — |
| Reported side effects | Nausea, vomiting, diarrhea, injection site reactions, hypoglycemia (when co-administered with sulfonylureas), rare acute pancreatitis, rare acute kidney injury | — |
Key differences
Primary use. Exenatide is categorised under Weight Management & Metabolic, while Icotrokinra falls under Immune Support. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Exenatide: FDA-approved. Icotrokinra: FDA-approved.
Dosing. Exenatide is typically dosed at 5–10 mcg (Byetta) or 2 mg (Bydureon/Bydureon BCise) (Twice daily (Byetta) or once weekly (Bydureon)). Typical dosing for Icotrokinra is not catalogued.
Can you stack them?
Some protocols combine peptides, but stacking Exenatide and Icotrokinra has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Exenatide and Icotrokinra?
- Exenatide is primarily a weight management & metabolic peptide, while Icotrokinra is used for immune support. Exenatide is FDA-approved for one or more indications, whereas Icotrokinra is FDA-approved for one or more indications.
- What is Exenatide used for?
- FDA-approved GLP-1 receptor agonist for type 2 diabetes; the first incretin mimetic approved in the US.
- What is Icotrokinra used for?
- Oral macrocyclic peptide. First-in-class IL-23 receptor antagonist. FDA approved March 17, 2026 for plaque psoriasis.
- Can you take Exenatide and Icotrokinra together?
- Some users combine peptides within a single protocol, but stacking Exenatide and Icotrokinra has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Exenatide or Icotrokinra FDA-approved?
- Exenatide is FDA-approved for one or more indications. Icotrokinra is FDA-approved for one or more indications.
Read the full articles
- Exenatide — full monograph: mechanism, research, dosing & references
- Icotrokinra — full monograph: mechanism, research, dosing & references